News

Fierce Pharma1d
Fierce Pharma Asia—Akeso bispecific's first survival readout; AstraZeneca's China probes; Ono's layoffs
Akeso's first overall survival readout for its Keytruda challenger caused a violent market reaction. AstraZeneca disclosed ...
AI In Healthcare Administration: A Comparison Of The EU, US And China
For executives racing to lead in healthcare AI, I see the European Union, the United States and China as the leading ...
AstraZeneca Sales, Earnings Rise; Faces China Tax Probe
The drugmaker posted increased core earnings per share and sales for the first quarter, but also said it could face a fine of ...
AstraZeneca says potential US tariffs manageable, faces another China fine
AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said on Tuesday, ...
AstraZeneca Q1 Earnings Rise, But China Drug Allegations May Lead To $8 Million Penalty
AstraZeneca posts Q1 revenue of $13.59 billion and a strong EPADS beat; oncology leads growth as China's tax probe and halts ...
AstraZeneca Sales, Earnings Rise; Warns of Mounting Legal Challenges in China — 2nd Update
AstraZeneca posted increased core earnings per share and sales for the first quarter but warned of mounting legal challenges in China.
AstraZeneca has built resilient supply chains in the U.S. and China for years, doesn't expect much tariff impact, CEO says
AstraZeneca CEO Pascal Soriot discusses earnings, the potential trade tariff impact on the business and the outlook for the ...
China Internet Information Center15d
China's general public budget spending up 4.2% in Q1
reflecting heightened enthusiasm in Chinese stock trading during the period. Follow China.org.cn on Twitter and Facebook to join the conversation.
Rest of World16d
Why Vietnam is in the middle of the U.S.-China trade war
In 2018, when Trump launched a trade war against China, Vietnam got a major opportunity to position itself as a politically safer region with plenty of affordable labor. Since then, Vietnam has ...